Ionis Pharmaceuticals Inc IONS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EDT
36.86UNCH (UNCH)
Volume
11,185
Close
36.86quote price arrow down-0.25 (-0.67%)
Volume
1,592,683
52 week range
25.04 - 44.42
Loading...
  • Open36.96
  • Day High37.75
  • Day Low35.93
  • Prev Close37.11
  • 52 Week High44.42
  • 52 Week High Date04/21/22
  • 52 Week Low25.04
  • 52 Week Low Date12/02/21

Key Stats

  • Market Cap5.227B
  • Shares Out141.80M
  • 10 Day Average Volume1.12M
  • Dividend-
  • Dividend Yield-
  • Beta0.75
  • YTD % Change21.13

KEY STATS

  • Open36.96
  • Day High37.75
  • Day Low35.93
  • Prev Close37.11
  • 52 Week High44.42
  • 52 Week High Date04/21/22
  • 52 Week Low25.04
  • 52 Week Low Date12/02/21
  • Market Cap5.227B
  • Shares Out141.80M
  • 10 Day Average Volume1.12M
  • Dividend-
  • Dividend Yield-
  • Beta0.75
  • YTD % Change21.13

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-1,335.51
  • Fwd P/E (NTM)-13.63
  • EBITDA (TTM)21.954M
  • ROE (TTM)-0.56%
  • Revenue (TTM)840.77M
  • Gross Margin (TTM)98.52%
  • Net Margin (TTM)-0.46%
  • Debt To Equity (MRQ)176.46%

EVENTS

  • Earnings Date08/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ionis Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company is primarily focused on our cardiovascular and neurology franchises. Its products include SPINRAZA, TEGSEDI and WAYLIVRA. SPINRAZA is for the treatment of patients of all ages with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. TEGSEDI is for the treatment of patients with polyneuropathy caused by...
Joseph Loscalzo M.D., Ph.D.
Independent Chairman of the Board
Brett Monia Ph.D.
Chief Executive Officer, Director
Elizabeth Hougen
Chief Financial Officer, Executive Vice President - Finance
Eric Swayze Ph.D.
Executive Vice President - Research
Eugene Schneider M.D.
Executive Vice President, Chief Clinical development Officer
Patrick O'Neil Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Address
2855 Gazelle Ct
Carlsbad, CA
92010-6670
United States

Top Peers

SYMBOLLASTCHG%CHG
PCRX
Pacira Biosciences Inc
60.23-0.42-0.69%
PBH
Prestige Consumer Healthcare Inc
55.97+0.33+0.59%
BPMC
Blueprint Medicines Corp
55.94+0.61+1.10%
HRMY
Harmony Biosciences Holdings Inc
43.20+1.70+4.10%
CORT
Corcept Therapeutics Inc
19.94-0.06-0.30%